Effects of the phlebotropic drug Daflon 500 mg on postischemic microvascular disturbances in striated skin muscle: An intravital microscopic study in the hamster

Journal of Laboratory and Clinical Medicine

Volumn 134, Issue 5, 1999, Pages 526-535

  Nolte, Dirk ^a   Pickelmann, Sven ^b   Möllmann, Matthias ^b   Schütze, Elke ^b   Kübler, Wolfgang ^b   Leiderer, Rosemarie ^b   Messmer, Konrad ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033230125     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90175-0     Document Type: Article

References (53)

1. 1. Roger CR. The nutritional incidence of flavonoids: some physiological and metabolic considerations. Experientia 1988;44:725-33.
2. 2. Bensath A, Ruysnyak T, Szent Györgyi A. Vitamin nature of flavones. Nature 1936;138:793-8.
3. 3. Kendall S, Towart R, Michel CC. Effects of hydroxyethylrutosides on the permeability of microvessels in the frog mesentery. Br J Pharmacol 1993;110:199-206.
4. 4. Hammersen F. The ultrastructural changes in the microcirculation in experimental edema: a suitable morphological test model for the effect of vaso-active drugs. Biorheology 1970;6:345-6.
5. 5. Gerdin B, Svensjö E. Inhibitory effect of the flavonoid O-(-hydroxy-ethyl)-rutosides on increased microvasular permeability induced by various agents in rat skin. Int J Microcirc Clin Exp 1983;2:39-46.
6. 6. Blumberg S, Clough G, Michel CC. Effects of hydroxyethylrutosides upon the permeability of single capillaries in the frog mesentery. Br J Pharmacol 1989;96:913-9.
7. 7. Meyer OC. Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease. Angiology 1994;45:579-84.
8. 8. Cospite M. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids. Angiology 1994;45:566-73.
9. 9. Middleton E Jr, Kandaswami C. Effects of flavonoids on immune and inflammatory cell functions. Biochem Pharmacol 1992;43:1167-79.
10. 10. Fewtrell CMS, Gomperts PD. Effects of flavone inhibitors of transport ATPases on histamine secretion from rat mast cells. Nature 1977;265:635-6.
11. 11. Pincemail J, Deby C, Thirion A, de Bruyn-Dister M, Goutier R. Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compounds. Experientia 1988;44:450-3.
12. 12. Bouskela E, Donyo KA. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in the hamster cheek pouch. Angiology 1997;48:391-9.
13. 13. Bouskela E, Donyo KA. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in diabetic hamsters. Int J Microcirc Clin Exp 1995;15:293-300.
14. 14. Nakayama T, Yamada M, Osawa T, Kawakishi S. Suppression of active oxygen-induced cytotoxicity by flavonoids. Biochem Pharmacol 1993;45:265-7.
15. 15. Blackburn WD, Heck LW, Wallace RW. The bioflavonoid quercetin inhibits neutrophil degranulation, superoxide production, and the phosphorylation of specific neutrophil proteins. Biochem Biophys Res Commun 1987;144:1229-36.
16. 16. Beretz A, Cazenavc JP. The effect of flavonoids on blood-vessel wall interactions. Prog Clin Biol Res 1988;280:187-200.
17. 17. Gryglewski RJ, Korbut R, Robak J, Swies J. On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol 1987;36:317-22.
18. 18. Granger DN, Benoit JN, Suzuki M, Grisham MB. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol 1989;257:G683-8.
19. 19. Schmid-Schoenbein GW. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 1987;46:2397-401.
20. 20. Nolte D, Menger MD, Messmer K. Microcirculatory models of ischemia-reperfusion injury in skin and striated muscle. Int J Microcirc Clin Exp 1995;15:9-16.
21. 21. Endrich B, Asaishi K, Goetz A, Messmer K. Technical report - a new chamber technique for microvascular studies in unanesthetized hamsters. Res Exp Med (Berl) 1980;177:125-34.
22. 22. Messmer K, Funk W, Endrich B, Zeintl H. The perspective of new methods in microcirculation research. Prog Appl Microcirc 1984;6:77-90.
23. 23. Menger MD, Hammersen F, Barker JH, Feifel G, Messmer K. Ischemia and reperfusion in skeletal muscle: experiments with tourniquet ischemia in the awake Syrian golden hamster. Prog Appl Microcirc 1989;13:93-108.
24. 24. Zeintl H, Sack F-U, Intaglietta M, Messmer K. Computer assisted leukocyte velocity measurement in intravital microscopy. Int J Microcirc Clin Exp 1989;8:293-302.
25. 25. Nolte D, Hecht R, Schmid P, et al. Role of Mac-1 and ICAM-1 in ischemia-reperfusion injury in a microcirculation model of BALB/c mice. Am J Physiol 1994;36:H1320-8.
26. 26. Sleinbauer M, Abels C, Harris AG, Messmer K. Intravital microscopy after ischemia-reperfusion in the striated muscle: adverse effects of fluorescent dyes? [abstract]. Int J Microcirc Clin Exp 1996;16:50.
27. 27. Friesenecker B, Tsai AG, Intaglietta M. Capillary perfusion during ischemia-reperfusion in subcutaneous connective tissue and skin muscle. Am J Physiol 1994;36:H2204-12.
28. 28. Nolte D, Zeintl H, Steinbauer M, Pickelmann S, Messmer K. Functional capillary density: an indicator of tissue perfusion? Int J Microcirc Clin Exp 1995;15:244-9.
29. 29. Kuebler WM, Abels C, Schuerer L, Goetz AE. Measurement of neutrophil content in brain and lung tissue by a modified myeloperoxidase-assay. Int J Microcirc Clin Exp 1996;16: 89-97.
30. 30. Pickelmann S, Nolte D, Moellmann M, Schuetze E, Leiderer R, Messmer K. Effects of the phlebotropic drug Daflon 500 mg on postischemic reperfusion injury in striated skin muscle: a histomorphologic study in the hamster. J Lab Clin Med 1998;134:536-45.
31. 31. Nolte D, Lehr HA, Sack FU, Messmer K. Reduction of postischemic reperfusion injury by the vasoactive drug buflomedil. Blood Vessels 1991;28(Suppl 1):8-14.
32. 32. Nolte D, Bayer M, Lehr HA, et al. Attenuation of postischemic microvascular disturbances in striated muscle by hyperosmolar saline dextran. Am J Physiol 1992;263;H1411-6.
33. 33. Lehr HA, Guhlmann A, Nolte D, Keppler D, Messmer K. Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest 1991;87:2036-41.
34. 34. Menger MD, Pelikan S, Steiner D, Messmer K. Microvascular ischemia-reperfusion injury in striated muscle: significance of "reflow paradox." Am J Physiol 1992;263: H1901-6.
35. 35. Menger MD, Steiner D, Messmer K. Microvascular ischemia-reperfusion injury in striated muscle - significance of no reflow. Am J Physiol 1992;263:H1892-900.
36. 36. Nolte D, Vestweber D, Hecht R, Messmer K. Monoclonal antibodies to L-selectin or P-selectin attenuate postischemic reperfusion injury in striated muscle. Langenbecks Arch Chir Forum 1995;399-403.
37. 37. Lefer AM, Weyrich AS, Buerke M. Role of selectins, a new family of adhesion molecules in ischemia-reperfusion injury. Cardiovasc Res 1994;28:289-94.
38. 38. Korthuis RJ, Granger DN, Townsley MI, Taylor AE. The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ Res 1985;57:599-609.
39. 39. Kumura E, Yoshimine T, Tanaka S, Hayakawa T, Shiga T, Kosaka H. Nitrosyl hemoglobin production during reperfusion after focal cerebral ischemia in rats. Neurosci Lett 1994;177:165-7.
40. 40. von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc Natl Acad Sci USA 1991;88:7538-42.
41. 41. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101.
42. 42. Goldman G, Welbourn R, Alexander S, et al. Modulation of pulmonary permeability in vivo with agents that affect the cytoskeleton. Surgery 1991;109:533-8.
43. 43. Frimmer M, Gries J, Hegner D. Studies on the mechanism of action of phalloidin. Release of lysosomal enzymes and potassium. Naunyn Schmiedebergs Arch Exp Pathol Pharmacol 1967;258:197-214.
44. 44. Korthuis RJ, Garden DL, Kvietys PR, Shepro D, Fuseler J. Phalloidin attenuates postischemic neutrophil infiltration and increased microvascular permeability. J Appl Physiol 1991;71:1261-9.
45. 45. Harris AG, Hecht R, Peer F, Nolte D, Messmer K. An improved intravital microscopy system. Int J Microcirc Clin Exp 1997;17:322-7.
46. 46. Calixto JB, Yunes RA. Natural bradykinin antagonists. Mem Inst Oswaldo Cruz 1991;86(Suppl 2):195-202.
47. 47. Cypriani B, Limasset B, Carrie ML, et al. Antioxidant activity of micronized diosmin on oxygen species from stimulated human neutrophils. Biochem Pharmacol 1993;45:1531-5.
48. 48. Friesenecker B, Tsai AG, Allegra C, Intaglietta M. Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia-reperfusion injury: in vivo observations in the hamster skinfold. Int J Microcirc Clin Exp 1994;14:50-5.
49. 49. Hayreh SS, Servais CE, Virdi PS. Retinal arteriolar changes in malignant arterial hypertension. Ophthalmologica 1989;198:178-96.
50. 50. Garner A, Ashton N, Tripathi R, Kohner EM, Bulpitt CJ, Dollery CT. Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol 1975; 59:3-44.
51. 51. Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders. Drugs 1992;44:1013-32.
52. 52. Becker M, Menger MD, Lehr HA. Heparin-released superoxide dismutase inhibits postischemic leukocyte adhesion to venular endothelium. Am J Physiol 1994;267:H925-30.
53. 53. House SD, Lipowsky HH. Leukocyte-endothelium adhesion: microhemodynamics in mesentery of the cat. Microvasc Res 1987;34:363-79.